Zeteo Biomedical, Author at Zeteo Biomedical

Zeteo Biomedical to Collaborate with Iowa State University Nanovaccine Institute to Study a COVID 19 Vaccine Under Fast Track CARES Act Funded Program

by Zeteo Biomedical | Nov 17, 2020 | Press Release

A nasal vaccine that can be self-administered is crucial to protect global populations against pandemic virus threats AUSTIN, TX – 17 November 2020 –(send2press)– Zeteo Biomedical LLC, Inc., a privately held medical device company, has partnered with the...

Zeteo Biomedical Introduces ZEOx1 AquilaMD™ Ophthalmic Drug Delivery System

by Zeteo Biomedical | Jun 1, 2020 | Press Release

Zeteo’s patient-centric ophthalmic delivery systems are designed for precise, self-administration of preservative free drugs and biopharmaceuticals AUSTIN, TX – 01 June 2020 — (PR.com) – Zeteo Biomedical LLC announced today the availability of the ZEOx1...

Zeteo Biomedical receives NIH Award to develop a universal nasal flu vaccine in collaboration with the Iowa State University Nanovaccine Institute

by Zeteo Biomedical | May 20, 2020 | Press Release

Vaccines that can be quickly manufactured, deployed and self-administered at global scale volumes is crucial to protect global populations against pandemic virus threats AUSTIN, TX – 20 May 2020 –(pr.com)– Zeteo Biomedical LLC, Inc., a privately held, medical...

Zeteo Biomedical Introduces ZEOx1 Orion™ Nasal Vaccine and Drug Delivery Systems

by Zeteo Biomedical | May 14, 2020 | Press Release

Zeteo’s patient-centric delivery systems are designed for quick manufacturing to facilitate rapid deployment of drugs and vaccines to global populations AUSTIN, TX – 14 May 2020 –(PR.com) – Zeteo Biomedical LLC announced today the availability of ZEOx1 Orion™...